Plasma growth hormone
Growth hormone releasing factors (GRFs) were isolated and characterized from pancreatic tumors in patients with acromegaly (Guillemin et al., 1982; Esch et al., 1982; Rivier et al., 1982) . More recently human hypothalamic GRF has been isolated and characterized from human pituitary stalkmedian eminence extract (Ling et al., 1984) . Its structure is identical to that of the 44-amino-acid GH-releasing peptide isolated from the tumor (Guillemin et al., 1982) .
Thus we shall only use the term hGRF to designate the human growth hormone releasing factor, tumors or hypothalamic. Using synthetic replicates of these human pancreatic GRFs (hGRFs), it has been demonstrated that some idiopathic GH deficient children have GH responses to a single iv bolus of hGRF-40 (Borges et al., 1983; Grossman et al., 1983) . We have also reported that forty percent of patients had GH responses to a single iv bolus administration of hGRF-44 (Takano et al., 1984) , repeated administrations of the TAKANO et al. Endocrinol. Japon. February 1985 peptide by either im, or iv infusion induced GH responses in the patients who did not respond to a single administration, and ultimately seventy percent of the patients had GH responses to hGRF-44 (Hizuka et al., 1984) .
In the present study, we have studied the effect of a single iv bolus administration of hGRF-44 and repeated iv boluses, iv infusions or im administrations of hGRF-44 on plasma somatomedin levels in patients with GH deficiency.
Materials and Methods
Human subjects Twenty-nine patients with pituitary dwarfism aged 6-30 were studied. Twenty-three of them were diagnosed as having idiopathic GH deficiency while the remaining six's GH deficiencies were secondary to hypothalamo-pituitary tumors. The clinical data on the 29 patients are summarized in Table 1 . The diagnosis of GH deficiency was established by failure of peak plasma GH to rise above 5ng/ml after insulininduced hypoglycemia (ITT) (Roth et al., 1963) , plasma somatomedin C, in spite of plasma GH rise. These findings are different from those reported by Borges et al. (1983) . They observed an increase in somatomedin C in 6 of 10 adult patients with GH deficiency after a single iv bolus administration of 10 hGRF-40/kg and their plasma GH re- idiopathic GH dificiency for five consecutive days (Takano et al., 1985) . However there was no effect on somatomedin C production. Thus, hGRF-44 stimulates plasma GH secretion in some patients with GH deficiency, however the increases are not enough to stimulate somatomedin generation. Nine of the patients with GH deficiency had normal somatomedin C levels before hGRF-44 administration.
Four of them had been studied in more than two types of our studies and showed low levels of somatomedin C on another occasions.
It is well known that somatomedins circulate in blood with carrier proteins and the carrier proteins are also regulated by hGH (Moses et al., 1976; Takano et al., 1979; Hintz and Liu 1980 
